Related Experiment Videos
Behavioral and biological factors associated with individual vulnerability to psychostimulant abuse
P V Piazza1, V Deroche, F Rougé-Pont
1INSERM U259, Université de Bordeaux II, France.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory.
Molecular psychiatry·2021
Opiate receptor modifications in the rat brain after chronic treatment with haloperidol and suipiride.
Journal of psychopharmacology (Oxford, England)·2012
Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
International journal of obesity (2005)·2011
Substance abuse vulnerability in offspring of alcohol and drug abusers.
NIDA research monograph·1998
Intracerebroventricular injection of neuropeptide Y suppresses luteinizing hormone pulses in mice.
Journal of neuroendocrinology·2026
[The use of psychedelics in psychiatry].
Orvosi hetilap·2026
Treatment-resistant Parkinson's disease psychosis responding to xanomeline-trospium: A case report.
Clinical parkinsonism & related disorders·2026
Case Report: Panic attack induced by albendazole in a post-PCI patient.
Frontiers in psychiatry·2026
Association between sleep paralysis and anxiety: a systematic review and meta-analysis.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026